Ashish Kamat, MD, MBBS, FACS

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Sessen Bio
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Imagin
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    US Biotest
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Asieris
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Medac
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Arquer
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/25/2023

Pages

Return to The Journal of Urology Vol. 210 (2023): November